BMY vs IOT · P/E 17, rev $24.46B vs P/E 348, rev $1.62B
Bristol-Myers Squibb Company (BMY) versus Samsara Inc (IOT) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Samsara Inc (IOT) is a software - infrastructure company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported IOT revenue for 2026-01-31 was $1.62B. Net income was -$9.1M. Revenue was up 29.6% from 2025-02-01 to 2026-01-31. IOT currently screens at market cap $20.28B and trailing P/E 348.0.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. IOT currently screens at market cap $20.28B and trailing P/E 348.0.
Not investment advice. Open the BMY and IOT stock pages for the full models.
Not investment advice.